MedPath

Determine If the Stress That Comes With Not Developing an Erection Affects Tadalafil Effects

Phase 4
Completed
Conditions
Impotence
Interventions
Registration Number
NCT00547599
Lead Sponsor
Eli Lilly and Company
Brief Summary

To determine if patients who are distressed over having problems getting or maintaining an erection react differently to the medication than those who are not stressed over the issue.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
659
Inclusion Criteria
  • 3 months history of erectile dysfunction (ED)
  • Anticipate a monogamous relationship with a female sexual partner
  • Be able to make minimum required sexual intercourse attempts
  • Abstain from using any other ED treatment
Exclusion Criteria
  • Nitrate use
  • Participated in previous tadalafil study or have a current tadalafil prescription
  • Heart attack within the last 90 days
  • Kidney problems
  • Certain heart problems

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
1tadalafil20 mg tadalafil tablet
Primary Outcome Measures
NameTimeMethod
Change In Spontaneity Domain of PAIRS scale scores8 weeks
Secondary Outcome Measures
NameTimeMethod
Change in the Time Concerns, Sexual Self-Confidence & Sexual Miscommunication, domains of PAIRS scale scores8 weeks

Trial Locations

Locations (1)

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

🇸🇪

Uppsala, Sweden

© Copyright 2025. All Rights Reserved by MedPath